A Natural History Study on CMT

Published on July 25th, 2019

Neurogene

Neurogene has enrolled the first patient in its natural history study on Charcot-Marie-Tooth disease type 4J.

The main goal is to hasten as possible the approval timeline for a future gene therapy medicine.

To know more about this future clinical trial, follow the link: https://bit.ly/2SysaTJ

To read latest news